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Prognosis of Human Diseases 
 
Appendix 1: Microarray Gene Expression Datasets 
 
 
We sought to evaluate the TSP algorithm against diverse diagnostic tasks in human medicine, 
and therefore acquired several microarray datasets representing diverse tissues and tissue types – 
including both solid tissues and circulating leukocytes. Additionally, we sought to evaluate the 
algorithm performance on both communicable diseases such as viral and bacterial infections, as 
well as somatic medical conditions such as Diabetes and Crohn’s Disease. Lastly, we included 
datasets employing several different microarray platforms and probe sets, to ascertain the 
robustness of the computational method to the experimental platform employed for data 
acquisition. 
 
The following is a description of the microarray datasets employed in this study. All microarray 
studies except for one – the GIST/LMS dataset, for which data was provided by the original 
authors of the study – were downloaded from the Gene Expression Omnibus; corresponding 
GEO dataset identifiers are shown in parentheses. GEO is a publicly accessible website 
containing several thousand microarray datasets for scientific use. This website and the studies 
included in the current manuscript can be obtained at: http://www.ncbi.nlm.nih.gov/geo/ 
 
 
Gastrointestinal Stromal Tumor (GIST) and Leiomyosarcoma (LMS) 
 
This study consisted of 68 primary tumor biopsies snap-frozen following surgical excision from 
patients with GIST (considered the ‘positive’ phenotype, with n = 37 samples) or LMS (n = 31 
samples), analyzed with an Agilent Technologies 44k human gene expression microarray. This 
original study derived a two-transcript classifier for this diagnostic task, which was found to 
compare favorably with standard histopathological measures for discriminating between the two 
related diseases. 
 
 
Crohn’s Disease (GDS1615) 
 
This study examined samples of peripheral blood mononuclear cells (PBMCs) isolated from 
patients with Crohn’s Disease, Ulcerative Colitis, and healthy status. We obtained gene 
expression profiles derived from patients diagnosed with Crohn’s Disease (n = 59), as well as 
healthy patients (n = 42). Transcription in each sample was profiled with an Affymetrix Human 
Genome U133A Array with approximately 22,000 probes. This original study created a 
transcription-based diagnostic classifier able to distinguish between Crohn’s Disease and 
Ulcerative Colitis using a panel of 12 genes. 
 
 
 
Ischemic and Idiopathic Cardiomyopathies (GSE5406) 
 
This study examined biopsies of left ventricular myocardium from patients with advanced stage 
ischemic or idiopathic cardiomyopathy during receipt of heart transplantation surgery, as well as 
several healthy controls from unused donor hearts. These tissues were analyzed with the 
Affymetrix Human Genome U133A Array containing approximately 22,000 probes. We 
obtained samples from ischemic cardiomyopathy patients (considered the ‘positive’ diagnosis, 
with n = 86 samples) and idiopathic cardiomyopathy patients (n = 108). This original study 
sought to determine genes differentially expressed within the two cardiomyopathy conditions in 
contrast to healthy patients. 
 
 
Type I and Type II Diabetes Mellitus (GSE9006) 
 
This study examined PBMCs isolated from healthy children, and children with Type I or Type II 
Diabetes. These samples were analyzed with Affymetrix Human Genome U133A and U133B 
arrays, each with approximately 22,000 probes. We compared samples from patients with Type I 
Diabetes (n = 81) with samples from healthy patients (n = 24), as well as patients with Type II 
Diabetes (n = 12) versus healthy control patients from the same microarray platform (n = 23). 
This study sought to profile gene expression changes observed in young patients diagnosed with 
different forms of Diabetes Mellitus to identify contributing transcriptional events in the 
pathogenesis of the disease, and identify prospective therapeutic targets. 
 
 
Ulcerative Colitis (GSE3629) 
 
This study examined samples obtained from surgically resected colon specimens from patients 
diagnosed with Ulcerative Colitis, with and without concomitant malignant transformation to 
colon cancer. Transcriptional profiling of these biopsies was performed with an Affymetrix 
Human Genome U133 Plus 2.0 Array containing approximately 54,000 unique probes. We 
obtained gene expression data for patients with transformed Ulcerative Colitis (n = 11) and non-
cancerous Ulcerative Colitis (n = 43). This original study applied support vector machine (SVM) 
and k-Nearest Neighbor algorithms to elucidate a 40-gene signature able to differentiate between 
transformed and non-transformed ulcerative colitis. 
 
 
Viral and Bacterial Infection (GSE6269) 
 
This study examined PBMCs isolated from individuals with acute bacterial or viral infections, 
which were then analyzed with Affymetrix Human Genome U133A and U133 Plus 2.0 arrays, 
containing 22,000 and 54,000 probes respectively. We obtained expression profiles for gram-
positive Staphylococcal infections (n = 29), gram-negative e. coli infections (n = 44), and 
influenza viral infections (n = 18). This original study performed a hierarchical clustering 
procedure to create a signature of 35 differentially expressed genes for the prediction of infection 
etiology. 
 
Human Immunodeficiency Virus Infection (GDS1449) 
 
This study examined PBMCs isolated from individuals with positive HIV diagnoses, and healthy 
HIV-negative patients. These samples were profiled using Affymetrix Human-Genome Focus 
Arrays with approximately 8800 probes. We obtained expression profiles for HIV seropositive 
individuals (n = 74) and HIV negative persons (n = 12). This study sought to reveal genes 
differentially regulated upon HIV infection and relevant to the pathogenesis of the disease. 
 
